J B Chemicals & Pharmaceuticals Ltd.

NSE: JBCHEPHARM | BSE: 506943 | ISIN: INE572A01036 | Industry: Pharmaceuticals
| Expensive Performer
1573.7000 -35.40 (-2.20%)
NSE Apr 25, 2025 15:31 PM
Volume: 209.7K
 

logo
J B Chemicals & Pharmaceuticals Ltd.
15 Nov 2021
1573.70
-2.20%
buy
by ICICI Securities Limited
Target: 2046
ICICI Securities Limited
JB Chemicals & Pharmaceuticals’ (JBCPL) Q2FY22 performance was better than estimates driven by strong growth in India business. EBITDA margin was lower than estimates owing to ESOPs charge. Consolidated revenue grew 33.7% YoY to Rs5.9bn and EBITDA margin dropped 340bps to 21.4%.
 
J B Chemicals & Pharmaceuticals Ltd.'s price crossed below 50Day SMA today
More from J B Chemicals & Pharmaceuticals Ltd.
Recommended
Five Interesting Stocks Today - April 25, 2025
The Baseline | 25 Apr 2025, 05:30PM
Market closes lower, Maruti Suzuki's Q4 net profit misses Forecaster estimates by 4%
Trendlyne Marketwatch | 25 Apr 2025, 03:56PM
New leadership, fresh strategy at JB Chemicals sees impact in Q1FY23
| 09 Sep 2022